Respiratory Syncytial Virus, RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization.
What is the best medicine to treat RSV? include the Ribavirin, antiviral drug which can be used in severe high-risk cases, and Bronchodilators. Your provider may try a breathing treatment with Albuterol, to assess whether the medication helps your child breathe better. This involves using a nebulizer to get the albuterol into the lungs. Usually, RSV will get better on its own without antibiotics.
Vaccination for RSV: CDC recommends adults > 60 years of age and older have the option to receive a single dose of RSV vaccine, based on discussions between the patient and their health care provider.
These are the 2 RSV vaccines that will be available:
Arexvy, by Glaxo Smith Kline.
Abrysvo™, made by Pfizer and advised by the Food and Drug Administration (FDA), for prevention of RSV-associated lower respiratory tract illness, in infants, from birth up to six months of age, by active immunization of pregnant women.
How long does RSV vaccine last? So far, RSV vaccines appear to provide some protection for at least two RSV seasons. Additional evaluation is planned to assess how long the protection lasts and whether additional doses will be needed.
Who should not get RSV vaccine? People younger than age < 60, including people with cancer, are not eligible for the vaccine.
